​
​

Alaunos Therapeutics Ownership | Who Owns Alaunos Therapeutics?

OverviewRevenueFinancialsChart

Alaunos Therapeutics Ownership Summary

100.00% retail investors. Eversource wealth advisors is the largest institutional shareholder, holding 0% of TCRT shares. Vanguard Institutional Extnd Mkt Idx Tr is the top mutual fund, with 1.28% of its assets in Alaunos Therapeutics shares.

TCRT Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockAlaunos Therapeutics--100.00%
SectorHealthcare Stocks 47.06%8.01%44.93%
IndustryBiotech Stocks 44.97%7.82%47.21%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Eversource wealth advisors---

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Eversource wealth advisors---

Top Buyers

HolderShares% AssetsChange
Eversource wealth advisors---40.00

Top Sellers

HolderShares% AssetsChange
Eversource wealth advisors---40.00

Sold Out

HolderChange
Eversource wealth advisors-40.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 20241-98.80%40-100.00%----100.00%--100.00%
Dec 31, 202383-9.78%41,174,501-26.49%173.14%17-27-3.57%
Sep 30, 202392-14.02%56,012,255-16.44%232.99%17-37.04%2816.67%
Jun 30, 2023107-7.76%67,033,956-5.32%273.21%27-6.90%24-22.58%
Mar 31, 2023116-10.77%70,801,563-9.01%292.30%29-44.23%316.90%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard Institutional Extnd Mkt Idx Tr20.47K1.28%-
Vanguard Total Stock Mkt Idx Inv17.35K1.08%-7.03K
Fidelity Extended Market Index9.09K0.57%787.00
BlackRock Extended Equity Market K2.98K0.19%-2.00
Fidelity Total Market Index2.38K0.15%-
Fidelity Series Total Market Index2.08K0.13%-
Fidelity Nasdaq Composite Index2.01K0.13%-
NT Ext Equity Mkt Idx Fd - L1.36K0.08%-
Northern Trust Extended Eq Market Idx1.36K0.08%-
NT Ext Equity Mkt Idx Fd - NL1.09K0.07%-

Recent Insider Transactions

DateNameRoleActivityValue
Sep 01, 2023Boyle Kevin S. Sr. Chief Executive OfficerSell$9.54K
Nov 29, 2022Postma Robert W-Buy$487.50K
Nov 29, 2022Vieser Jaime-Buy$812.50K
Dec 22, 2021De Groot Eleanor EVP, OperationsSell$25.57K
Nov 17, 2021Boyle Kevin S. Sr. Chief Executive OfficerBuy$12.76K

Insider Transactions Trends

DateBuySell
2024 Q3--
2024 Q2--
2024 Q1--
2023 Q4--
2023 Q3-1

TCRT Ownership FAQ

Who Owns Alaunos Therapeutics?

Alaunos Therapeutics shareholders are primarily institutional investors at 0.00%, followed by 0% insiders and 0% retail investors. The average institutional ownership in Alaunos Therapeutics's industry, Biotech Stocks , is 44.97%, which Alaunos Therapeutics falls below.

Does Blackrock own Alaunos Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Alaunos Therapeutics.

Who is Alaunos Therapeutics’s biggest shareholder by percentage of total assets invested?

Eversource wealth advisors is Alaunos Therapeutics’s biggest shareholder by percentage of total assets invested, with 0% of its assets in 0 Alaunos Therapeutics shares, valued at 0$.

Who is the top mutual fund holder of Alaunos Therapeutics shares?

Vanguard Institutional Extnd Mkt Idx Tr is the top mutual fund holder of Alaunos Therapeutics shares, with 1.28% of its total shares outstanding invested in 20.47K Alaunos Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools